检索历史清除

首页> Blood: The Journal of the American Society of Hematology> Impact of Somatic Gene Mutations on Response to Lenalidomide (LEN) in IPSS Lower-Risk Myelodysplastic Syndromes (MDS) Patients (Pts) without Del(5q) and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents (ESAs)

Impact of Somatic Gene Mutations on Response to Lenalidomide (LEN) in IPSS Lower-Risk Myelodysplastic Syndromes (MDS) Patients (Pts) without Del(5q) and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents (ESAs)

导出原文传递

翻译打印收藏纠错

作者： Santini, Valeria ; Fenaux, Pierre ; Giagounidis, Aristoteles ; Platzbecker, Uwe ; List, Alan F. ; Zhong, Jianhua ; Wu, Chengqing ; Mavrommatis, Konstantinos ; Beach, C. L. ; Hoenekopp, Albert ; MacBeth, Kyle J.

发布时间 2020-08-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交